Links
Archives
- Mar 11, 2004
- Mar 12, 2004
- Mar 13, 2004
- Mar 14, 2004
- Mar 20, 2004
- Apr 1, 2004
- Apr 7, 2004
- Apr 30, 2004
- May 19, 2004
- Jun 5, 2004
- Jul 18, 2004
- Aug 11, 2004
- Aug 30, 2004
- Aug 31, 2004
- Sep 4, 2004
- Sep 20, 2004
- Sep 24, 2004
- Sep 27, 2004
- Oct 7, 2004
- Oct 9, 2004
- Oct 16, 2004
- Oct 17, 2004
- Jan 7, 2005
- Oct 12, 2006
- Apr 12, 2007
- Apr 13, 2007
- Apr 15, 2007
- Apr 26, 2007
- May 9, 2007
- Nov 4, 2007
- Mar 21, 2008
My thoughts and learning experiences regarding cellular immunology, cytokine assays and biology in general.
Thursday, April 26, 2007
This article talks about how the US government is attempting to develop a new, safer vaccine against smallpox. This is part of an attempt to protect the country against the threat of bioterrorism--that is, the use of weaponized pathogens.
The article talked about how monkeys have been used to test the efficacy of the vaccine. Inoculated monkeys are exposed to the monkeypox virus, which closely resembles smallpox. The researchers then determine if the vaccine provides any protection against the virus.
Obviously, it would be unethical to test the vaccine on humans in the same fashion. (Heck, it's hard enough testing them on monkeys! How tragic.) Fortunately, the ELISPOT technique allows the immune response to be monitored ex vivo; that is, without injecting any pathogens into a human host.
The article talked about how monkeys have been used to test the efficacy of the vaccine. Inoculated monkeys are exposed to the monkeypox virus, which closely resembles smallpox. The researchers then determine if the vaccine provides any protection against the virus.
Obviously, it would be unethical to test the vaccine on humans in the same fashion. (Heck, it's hard enough testing them on monkeys! How tragic.) Fortunately, the ELISPOT technique allows the immune response to be monitored ex vivo; that is, without injecting any pathogens into a human host.